Prosecution Insights
Last updated: November 08, 2026
Application No. 17/780,959

SULFUR FUNCTIONALIZED MONOLITHS AND PARTICLES DERIVED FROM THE SAME AS NITRIC OXIDE CARRIERS FOR PHARMACEUTICAL AND COSMETIC APPLICATIONS

Non-Final OA §103
Filed
May 27, 2022
Priority
Jun 19, 2019 — provisional 62/863,503 +1 more
Examiner
HOLT, ANDRIAE M
Art Unit
1614
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Zylo Therapeutics Inc.
OA Round
3 (Non-Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
381 granted / 769 resolved
-10.5% vs TC avg
Strong +23% interview lift
Without
With
+23.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
29 currently pending
Career history
807
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
50.1%
+10.1% vs TC avg
§102
14.7%
-25.3% vs TC avg
§112
21.1%
-18.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 769 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Acknowledgement of Receipt Applicant's response filed on 05/31/2025 to the Office Action mailed on 02/05/2025 is acknowledged. Claim Status Claims 22-42 are pending. Claims 22, 27, 31, and 37-38 are currently amended. Claims 31-42 have been previously withdrawn. Claims 1-21 are previously canceled. Claims 22-30 have been examined. Claims 22-30 are rejected. New (Modified) Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. This rejection is modified from the previous Office Action in view of the amendments to the claims. Claims 22-30 are rejected under 35 U.S.C. 103 as being unpatentable over Zheng et al. (Hybrid organic–inorganic silica monolith with hydrophobic/strong cation-exchange functional groups as a sorbent for micro-solid phase extraction, Sep. 6, 2009) (hereinafter Zheng) in view of Chen et al. (Preparation of organic–inorganic hybrid silica monolith with octyl and sulfonic acid groups for capillary electrochromatograhpy and application in determination of theophylline and caffeine in beverage, April 2, 2010) (hereinafter Chen) and Ali et al., (Polystyrene bound silica monolith particles of reduced size as stationary phase of excellent separation efficiency in high performance liquid chromatograhy, Feb. 7, 2019) (hereinafter Ali). Zheng discloses a hybrid silica monolith synthesized (i.e., formed) by hydrolysis and polycondensation of a mixture of tetraethoxysilane (TEOS) (i.e., tetraethyl orthosilicate), n-octyltriethoxysilane (C8-TEOS) and 3-mercaptopropyltrimethoxysilane (MPTMS) via a two-step catalytic sol–gel process (Abstract). Tetraethoxysilane (98%, TEOS) and 3-mercaptopropyltrimethoxysilane (95%, MPTMS) were used directly without further purification (page 7740, Experimental, first paragraph). A mixed stock solution of all standards was prepared in acetonitrile at a concentration of 1mg/mL and stored at 4 ◦C in the dark. The standard solution was diluted to the desired concentration for experiments (page 7740, second column, first paragraph). Fused-silica capillaries were prepared then the hybrid monolith was synthesized by hydrolysis and polycondensation of precursors via a two-step catalytic sol–gel process. The optimal preparation conditions include 180 µL of methanol, 25 µL of 0.5M HCl, various amounts of C8-TEOS, MPTMS and 110 µL TEOS were mixed together. 60, 65 and 70 µL of C8-TEOS in the original sols were used for the preparation of columns A, B and C, respectively. The total volume of C8-TEOS and MPTMS was kept at 100 µL. After thorough vortexing, the mixture was left for hydrolysis at 60 ◦C for 5 h. After cooling to room temperature, 10mg of n-dodecylamine (i.e., a base) was added to the solution. Then the pretreated capillary was filled to a certain length with the sol by a syringe (page 7740, Preparation of hybrid silica monolith). The hybrid monolith was later treated with 5 mM phosphate solution (pH 10.5) for 12 h (page 7745, Table 5). Zheng differs from the instant claims insofar as not disclosing a ratio of the molar amount of the first monomer (i.e., 3-mercaptopropyltrimethoxysilane) to the molar amount of the second monomer (i.e., tetraethyl orthosilicate) within a range of from 1:3 to 4:6 or 35:65 to 40:60. However, Chen teaches an organic–inorganic hybrid silica monolith optimized by changing the composition of tetraethoxysilane (TEOS), octyltriethoxysilane (C8-TEOS) and 3-mercaptopropyltrimethoxysilane (MPTMS) in the mixture of precursors (Abstract). Three precursors, namely tetraethoxysilane (TEOS), 3-mercaptopropyltrimethoxysilane (MPTMS), and octyltriethoxysilane (C8-TEOS), were mixed in a certain ratio in order to obtain monolithic columns with better kinetic and thermodynamic performance (page 3548, first column, third paragraph). Table 1 shows the influence of precursors content in mixtures on monolithic column preparation (page 3550). Accordingly, since ratio of TEOS and MPTMS affects the kinetic and thermodynamic performance of monolithic columns, it would have taken no more than the relative skills of one of ordinary skill in the art through routine experimentation to have arrived at the claimed ratio based on arriving at a monolith with desirable kinetic and thermodynamic performance as taught by Chen. Generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. Where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. See MPEP 2144.05. The combined teachings of Zheng and Chen do not disclose breaking the monolith to form particles. However, Ali teaches ground silica monolith particles prepared by a sol-gel process followed by soft grinding and calcination (Abstract). The resultant silica monolith particles are packed in micro-columns that have shown excellent separation efficiencies. The character of multiple shapes of phases (ground silica monolith particles) is also believed to greatly contribute to the enhanced separation efficiency (page 73, Effect of particles texture on chromatographic performance). Accordingly, it would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the instant application to produce particles by forming a monolith and breaking at least some of the monolith to form said particles by soft grinding since it was known in the art that grinding a silica monolith can be beneficial in certain applications, such as separation efficiency as taught by Ali. Response to Applicant’s Arguments With regard to the rejection of claims 22-30 under 35 U.S.C. 103 as being unpatentable over Zheng et al. (Hybrid organic–inorganic silica monolith with hydrophobic/strong cation-exchange functional groups as a sorbent for micro-solid phase extraction, Sep. 6, 2009) (hereinafter Zheng) in view of Chen et al. (Preparation of organic–inorganic hybrid silica monolith with octyl and sulfonic acid groups for capillary electrochromatograhpy and application in determination of theophylline and caffeine in beverage, April 2, 2010) (hereinafter Chen) and Ali et al., (Polystyrene bound silica monolith particles of reduced size as stationary phase of excellent separation efficiency in high performance liquid chromatograhy, Feb. 7, 2019) (hereinafter Ali): Applicant argues that Zheng does not disclose forming a monolith. Applicant’s argument has been fully considered but found not to be persuasive. Zheng discloses a hybrid silica monolith synthesized (i.e., formed) by hydrolysis and polycondensation of a mixture of tetraethoxysilane (TEOS) (i.e., tetraethyl orthosilicate), n-octyltriethoxysilane (C8-TEOS) and 3-mercaptopropyltrimethoxysilane (MPTMS) via a two-step catalytic sol–gel process (Abstract). Applicant argues that Zheng discloses making a sol and applying the sol to an existing substrate monolith to modify the surface of the existing monolith. Applicant’s argument has been fully considered but found not to be persuasive. Zheng discloses fused-silica capillaries were prepared then the hybrid monolith was synthesized by hydrolysis and polycondensation of precursors via a two-step catalytic sol–gel process wherein various amounts of C8-TEOS, MPTMS and TEOS were mixed together and the pretreated capillary was filled to a certain length with the sol by a syringe (page 7740, Preparation of hybrid silica monolith). Accordingly, Zheng teaches initiating condensation of the mixture to form a sol-gel monolith, as recited in claim 22. Claim 22 as recited does not exclude the formation of a sol-gel monolith from combing sol with silica capillaries in a catalytic process. Applicant argues that because in Zheng, the precursors are condensing onto the existing silica substrate, Zheng does not perform condensation of a monomer mixture to form a monolith. Applicant’s argument has been fully considered but found not to be persuasive for reasons discussed above. Claim 22 as recited does not exclude the formation of a sol-gel monolith by condensing the precursors (i.e., monomer mixture) onto the existing silica substrate. Applicant argues that neither Chen nor Ali remedy the deficiencies of Zheng. Applicant’s argument has been fully considered but found not to be persuasive because Applicant’s arguments against Zheng were not found to be persuasive. Applicant argues that claims 31-42 should be allowed by rejoinder. Applicant’s argument has been fully considered but found not to be persuasive because Applicant’s arguments against Zheng, Chen, and Ali regarding the elected group were not found to be persuasive. For the foregoing reasons the rejection is modified and maintained. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Samantha J Knight whose telephone number is (571)270-3760. The examiner can normally be reached Monday - Friday 8:30 am to 5:00 pm ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ali Soroush can be reached at (571)272-9925. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /S.J.K./ Examiner, Art Unit 1614 /ALI SOROUSH/ Supervisory Patent Examiner, Art Unit 1614
Read full office action

Prosecution Timeline

Show 5 earlier events
Dec 16, 2025
Response after Non-Final Action
Dec 16, 2025
Request for Continued Examination
May 08, 2026
Response after Non-Final Action
Jun 07, 2026
Request for Continued Examination
Jun 08, 2026
Response after Non-Final Action
Sep 09, 2026
Applicant Interview (Telephonic)
Sep 09, 2026
Examiner Interview Summary
Nov 05, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12772977
USE OF BENZYL ALCOHOL AS A HERBICIDE
4y 4m to grant Granted Oct 27, 2026
Patent 12772980
HERBICIDAL COMPOSITIONS
1y 4m to grant Granted Oct 27, 2026
Patent 12757894
AQUEOUS HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF
4y 8m to grant Granted Oct 13, 2026
Patent 12757899
USE OF ACYLCYANAMIDES OR SALTS THEREOF FOR REGULATING PLANT GROWTH
4y 5m to grant Granted Oct 13, 2026
Patent 12757898
AGROCHEMICAL ADJUVANTS
3y 8m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
73%
With Interview (+23.1%)
3y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 769 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month